Exploration of critical parameters for transient retrovirus production (Q42800478)

7 November 2017

Exploration of critical parameters for transient retrovirus production (English)

1 reference

7 November 2017

3

1 reference

7 November 2017

Marcio C Bajgelman

1

1 reference

PubMed ID

12814868

7 November 2017

Eugenia Costanzi-Strauss

series ordinal

2

1 reference

7 November 2017

1 June 2003

1 reference

7 November 2017

Journal of Biotechnology

1 reference

7 November 2017

103

1 reference

7 November 2017

2

1 reference

7 November 2017

97-106

1 reference

A triploblast origin for Myxozoa?

7 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Removal of proteoglycans increases efficiency of retroviral gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Kinetics of retrovirus production and decay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Effects of culture parameters on the production of retroviral vectors by a human packaging cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Gene therapy: the first decade

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

A mechanism for the control of protein synthesis by adenovirus VA RNAI.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

A transient three-plasmid expression system for the production of high titer retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Generation of retroviral vector for clinical studies using transient transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

Effects of stoichiometry of retroviral components on virus production

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2803%2900103-2

7 January 2021

10.1016/S0168-1656(03)00103-2

Identifiers

DOI

1 reference

7 November 2017

1 reference

PubMed ID

12814868